NCT07008456View on ClinicalTrials.gov

A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

PHASE2RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Obese With ComorbiditiesObese Patients (BMI ≥ 30 kg/m²)
Interventions
DRUG

APHD-012

12 g dextrose beads

DRUG

APHD-002

2 g dextrose beads

DRUG

APHP-012

12 g placebo beads

DRUG

APHP-002

2 g placebo beads

Trial Locations (6)

0112

RECRUITING

"LTD Israeli-Georgian Medical Research Clinic Healthycore", Tbilisi

0114

RECRUITING

"LTD New Hospitals", Tbilisi

0159

RECRUITING

"LTD Acad. G. Chapidze Emergency Cardiology Center", Tbilisi

RECRUITING

"LTD Diacor", Tbilisi

RECRUITING

"NNLE Jo Ann University Hospital", Tbilisi

0180

RECRUITING

LTD The First Medical Center, Tbilisi

Sponsors
All Listed Sponsors
lead

Aphaia Pharma US LLC

INDUSTRY

NCT07008456 - A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities | Biotech Hunter | Biotech Hunter